Photodynamic Therapy in Head and Neck Cancer
- 1 June 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 111 (6) , 351-355
- https://doi.org/10.1001/archotol.1985.00800080037001
Abstract
• A group of 24 patients with recurrent and/or metastatic cancers were treated with photodynamic therapy using hematoporphyrin derivative (HpD) to study feasibility of this new technique. This experience demonstrated that photodynamic therapy is possible for head and neck cancer and that the toxic reactions and complications are minimal. The short durations of response in this group of patients most probably are a reflection of current lack of understanding about what represents maximal tolerable doses of HpD and frequencies of treatment. (Arch Otolaryngol 1985;111:351-355)This publication has 11 references indexed in Scilit:
- DNA damage and repair in CHO cells following hematoporphyrin photoradiationPublished by Elsevier ,2004
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981
- AUTORADIOGRAPHIC DISTRIBUTION OF HEMATOPORPHYRIN DERIVATIVE IN NORMAL AND TUMOR-TISSUE OF THE MOUSE1981
- DNA SINGLE-STRAND BREAKS AND SISTER CHROMATID EXCHANGES INDUCED BY TREATMENT WITH HEMATOPORPHYRIN AND LIGHT OR BY X-RAYS IN HUMAN NHIK-3025 CELLS1980
- DETERMINATION OF [HEMATOPORPHYRIN-H-3] AND [HEMATOPORPHYRIN-C-14 DERIVATIVE DISTRIBUTION IN MALIGNANT AND NORMAL TISSUE1979
- PHOTORADIATION THERAPY FOR TREATMENT OF MALIGNANT-TUMORS1978
- Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cellsBiochemistry, 1977
- Photodynamic action of protoporphyrin IX on human erythrocytes: Cross-linking of membrane proteinsBiochemical and Biophysical Research Communications, 1976
- Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the BladderJournal of Urology, 1976
- Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrinCancer, 1955